<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7229764\results\search\disease\results.xml">
  <result pre="influenza vaccination and public health interventions on COVID-19 epidemics with" exact="limited" post="detection capability LiQianabTangBiaobBragazziNicola LuigibXiaoYanniaWuJianhongwujh@yorku.cabâ�Ž[a], [b], â�ŽCorresponding author. wujh@yorku.ca pmc-release:"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="symptoms, potentially at risk of contracting COVID-19 or other emerging/re-emerging" exact="respiratory" post="infectious agents during their admission at the health-care setting,"/>
  <result pre="potentially at risk of contracting COVID-19 or other emerging/re-emerging respiratory" exact="infectious" post="agents during their admission at the health-care setting, who"/>
  <result pre="mass influenza vaccination on the spread of COVID-19 and other" exact="respiratory" post="pathogens in the case of a coincidence of the"/>
  <result pre="enhancing the public health interventions would facilitate the management of" exact="respiratory" post="outbreaks coinciding with the peak flu season, especially, compensate"/>
  <result pre="uptake. Highlights â€¢A novel COVID-19 mathematical model incorporating cross-infection and" exact="limited" post="detection capability is proposed. â€¢Mass influenza vaccination is verified"/>
  <result pre="compensate the shortage of detection resource. Keywords Coronavirus Pandemic outbreak" exact="Limited" post="resources Influenza season Influenza vaccination 1 Introduction An emerging"/>
  <result pre="vaccination 1 Introduction An emerging coronavirus, currently known as â€œSevere" exact="Acute" post="Respiratory Syndrome coronavirus type 2â€� (SARS-CoV-2) and previously termed"/>
  <result pre="1 Introduction An emerging coronavirus, currently known as â€œSevere Acute" exact="Respiratory" post="Syndrome coronavirus type 2â€� (SARS-CoV-2) and previously termed as"/>
  <result pre="Introduction An emerging coronavirus, currently known as â€œSevere Acute Respiratory" exact="Syndrome" post="coronavirus type 2â€� (SARS-CoV-2) and previously termed as â€œ2019"/>
  <result pre="standpoint, it would be difficult to distinguish between the two" exact="infectious" post="agents, with the definition of COVID-19 cases rather problematic."/>
  <result pre="tests are characterized by a good specificity but have a" exact="limited" post="sensitivity, as such not enabling a quick and reliable"/>
  <result pre="would increase the likelihood of nosocomial transmission. When the â€œSevere" exact="Acute" post="Respiratory Syndromeâ€� (SARS) outbreak caused by the coronavirus SARS-CoV-1"/>
  <result pre="increase the likelihood of nosocomial transmission. When the â€œSevere Acute" exact="Respiratory" post="Syndromeâ€� (SARS) outbreak caused by the coronavirus SARS-CoV-1 occurred"/>
  <result pre="to be able to differentiate more quickly between the two" exact="infections" post="and to be more effective in counteracting the outbreakÂ"/>
  <result pre="symptoms, potentially at risk of contracting COVID-19 or other emerging/re-emerging" exact="respiratory" post="infectious agents during their admission at the health-care setting,"/>
  <result pre="potentially at risk of contracting COVID-19 or other emerging/re-emerging respiratory" exact="infectious" post="agents during their admission at the health-care setting, where"/>
  <result pre="shown in Fig.Â 2. In the model, we divide the" exact="total" post="population N into ten compartments: susceptible ( S), exposed"/>
  <result pre="N into ten compartments: susceptible ( S), exposed ( E)," exact="symptomatic" post="infected ( I), asymptomatic infected ( A), quarantined susceptible"/>
  <result pre="the model adopted in the study for illustrating the COVID-19" exact="infection" post="dynamics. Interventions including intensive contact tracing followed by quarantine"/>
  <result pre="contact tracing followed by quarantine and isolation are indicated. The" exact="total" post="suspected cases consisting of quarantined susceptible with clinical fever"/>
  <result pre="of the quarantined infected class ( I q ) with" exact="limited" post="testing capacity, respectively. Î´ I and Î´ q are"/>
  <result pre="1 Ï‰ b , where 1 Ï‰ 0 is the" exact="total" post="number of available detection kits at the initial time"/>
  <result pre="quarantined susceptibles with fever symptoms 0.1 Estimated Ï� Ratio of" exact="symptomatic" post="infection 0.5 Estimated Ïƒ Transition rate of exposed individuals"/>
  <result pre="susceptibles with fever symptoms 0.1 Estimated Ï� Ratio of symptomatic" exact="infection" post="0.5 Estimated Ïƒ Transition rate of exposed individuals to"/>
  <result pre="0 7 Estimated E Exposed population 8216 Estimated I Infected" exact="symptomatic" post="population 1000 Estimated A Infected asymptomatic population 1000 Estimated"/>
  <result pre="1 n y i âˆ’ y Â¯ 2 denoting the" exact="total" post="sum of squares. Therefore, we obtain the coefficients of"/>
  <result pre="the model fits the data very well. 3.2 Impacts of" exact="limited" post="detection kits Detection kits for COVID-19 were firstly introduced"/>
  <result pre="introduced and used on January 16th 2020, but with very" exact="limited" post="number. Since January 23rd 2020, detection kits were delivered"/>
  <result pre="of the COVID-19 epidemics. To examine the impacts of the" exact="limited" post="detection kits on the COVID-19 epidemics in terms of"/>
  <result pre="rate r Ï‰ decreases by 80 percent. This means that" exact="deficiency" post="and delay of detection cause more serious outbreaks. In"/>
  <result pre="in reducing the final size of infections. When faced with" exact="limited" post="detection kits supply, we show the impacts of public"/>
  <result pre="kits, and it is more indispensable for countries with severe" exact="limited" post="resource of detection kits. Fig. 4 The effects of"/>
  <result pre="on the cumulative number of confirmed cases when faced with" exact="limited" post="detection kits supply. Value of r Ï‰ Cumulative number"/>
  <result pre="the threshold 1 directly. This indicates that due to the" exact="limited" post="resource of the testing kits, the fast-increased infected population"/>
  <result pre="testing kits, the fast-increased infected population will result in more" exact="infections" post="as they are not confirmed and hospitalized. And the"/>
  <result pre="avert the short-term intensification of the outbreak caused by the" exact="limited" post="detection kits. Fig. 5 (A) Estimated effective reproduction number"/>
  <result pre="number of confirmed cases can reduce by 23.0% (about 19062" exact="total" post="cases), moreover, the cumulative number of cross-infected cases can"/>
  <result pre="of confirmed cases and cross-infected cases incorporating the effect of" exact="limited" post="testing kits and public health interventions, that is, with"/>
  <result pre="influenza vaccination is more necessary when detection kits are severely" exact="limited" post="and under seriously shortage of supply. In another words,"/>
  <result pre="with a rapid growth and the countries or areas with" exact="limited" post="testing kits. Fig. 7 The total reduction number of"/>
  <result pre="countries or areas with limited testing kits. Fig. 7 The" exact="total" post="reduction number of cumulatively confirmed cases and the reduction"/>
  <result pre="potentially at risk of developing the COVID-19 (or other emerging" exact="respiratory" post="infections) during their admission at the health-care setting. Our"/>
  <result pre="the onset of the influenza season, the exposure of emerging/re-emerging" exact="respiratory" post="pathogens would be unmasked, facilitating their identification and the"/>
  <result pre="would significantly alleviate the pressure on health-care facilities, reducing the" exact="total" post="number of people complaining of ILI symptoms, and decreasing"/>
  <result pre="and decreasing the transmission probability of COVID-19 or other emerging" exact="infectious" post="agents both among healthcare workers and, subsequently, among people"/>
  <result pre="a relevant burden worldwide, both in terms of healthcare resources" exact="consumption" post="and socio-economic impact. Despite the existence of effective vaccines"/>
  <result pre="workers are at a higher risk of exposure to circulating" exact="respiratory" post="pathogens, including influenza, potentially threatening their own health and"/>
  <result pre="targeted categories, including the elderly and disabled people. An inadequate" exact="disease" post="risk perception, a low health literacy, perception of the"/>
  <result pre="minimize the probability of not quickly and accurately identifying circulating" exact="respiratory" post="pathogens as well as the possibility of ongoing nosocomial"/>
  <result pre="strategies to improve influenza vaccine uptake, given its impact on" exact="respiratory" post="pandemic outbreaks coinciding with the peak influenza season and"/>
  <result pre="a modelling impact assessmentLancet3951023320201382139332277878 3LinQ.Y.ZhaoS.GaoD.Z.WangW.M.YangL.HeD.H.A conceptual model for the coronavirus" exact="disease" post="2019 (COVID-19) outbreak in Wuhan, China with individual reaction"/>
  <result pre="Infect. Dis.202010.1016/j.ijid.2020.03.018 13collab: Special Expert Group for Control of the" exact="Epidemic" post="of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine"/>
  <result pre="Expert Group for Control of the Epidemic of Novel Coronavirus" exact="Pneumonia" post="of the Chinese Preventive Medicine Association, The Chinese Preventive"/>
  <result pre="Medicine AssociationAn update on the epidemiological characteristics of novel coronavirus" exact="pneumonia" post="(COVID-19)Chin. J. Epidemiol.412020139144 14TangB.BragazziN.L.LiQ.TangS.Y.XiaoY.N.WuJ.H.An updated estimation of the risk"/>
 </snippets>
</snippetsTree>
